Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marshall Plaut

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Allergy and Clinical Immunology|June 15, 2020
Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergyEdwin H Kim, Tamara T Perry, Robert A Wood, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2016
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapyStacie M Jones, A Wesley Burks, Corinne Keet, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy ResearchAmy M Scurlock, A Wesley Burks, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2017
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adultsStacie M Jones, Scott H Sicherer, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2015
Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergyLisa M Wheatley, Marshall Plaut, Julie M Schwaninger, et al.
NEJM Evidence|May 28, 2024
Follow-up to Adolescence after Early Peanut Introduction for Allergy PreventionGeorge Du Toit, Michelle F Huffaker, Suzana Radulovic, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2023
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatmentEric L Simpson, Patrick M Schlievert, Takeshi Yoshida, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2019
Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ WorkshopLisa M Wheatley, Robert Wood, Kari Nadeau, et al.
Lancet (London, England)|January 23, 2022
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled studyStacie M Jones, Edwin H Kim, Kari C Nadeau, et al.
The Journal of Allergy and Clinical Immunology|January 15, 2019
Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions"Wendy F Davidson, Donald Y M Leung, Lisa A Beck, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Allergy and Clinical Immunology|June 15, 2020
Induction of sustained unresponsiveness after egg oral immunotherapy compared to baked egg therapy in children with egg allergyEdwin H Kim, Tamara T Perry, Robert A Wood, et al.
The Journal of Allergy and Clinical Immunology|March 1, 2016
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapyStacie M Jones, A Wesley Burks, Corinne Keet, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy ResearchAmy M Scurlock, A Wesley Burks, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2017
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adultsStacie M Jones, Scott H Sicherer, A Wesley Burks, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2015
Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergyLisa M Wheatley, Marshall Plaut, Julie M Schwaninger, et al.
NEJM Evidence|May 28, 2024
Follow-up to Adolescence after Early Peanut Introduction for Allergy PreventionGeorge Du Toit, Michelle F Huffaker, Suzana Radulovic, et al.
The Journal of Allergy and Clinical Immunology|June 14, 2023
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatmentEric L Simpson, Patrick M Schlievert, Takeshi Yoshida, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2019
Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ WorkshopLisa M Wheatley, Robert Wood, Kari Nadeau, et al.
Lancet (London, England)|January 23, 2022
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled studyStacie M Jones, Edwin H Kim, Kari C Nadeau, et al.
The Journal of Allergy and Clinical Immunology|January 15, 2019
Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions"Wendy F Davidson, Donald Y M Leung, Lisa A Beck, et al.
Pageof 6